SMPD3
Basic information
Region (hg38): 16:68358327-68448508
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SMPD3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 46 | 47 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 46 | 1 | 0 |
Variants in SMPD3
This is a list of pathogenic ClinVar variants found in the SMPD3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-68361213-T-G | not specified | Uncertain significance (Oct 12, 2021) | ||
16-68361243-A-G | not specified | Uncertain significance (Nov 15, 2024) | ||
16-68361271-C-T | not specified | Uncertain significance (Apr 12, 2024) | ||
16-68361655-C-T | not specified | Uncertain significance (Apr 15, 2024) | ||
16-68361685-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
16-68361686-G-A | not specified | Uncertain significance (May 21, 2024) | ||
16-68363530-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
16-68363539-C-T | not specified | Uncertain significance (Jan 22, 2024) | ||
16-68363546-G-C | not specified | Uncertain significance (Nov 24, 2024) | ||
16-68363812-C-T | not specified | Uncertain significance (Aug 17, 2021) | ||
16-68364819-G-A | not specified | Uncertain significance (Aug 28, 2023) | ||
16-68364891-C-T | not specified | Uncertain significance (Sep 22, 2022) | ||
16-68365044-C-T | not specified | Uncertain significance (Aug 21, 2024) | ||
16-68365056-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
16-68365082-C-T | not specified | Uncertain significance (Jun 04, 2024) | ||
16-68370897-C-T | not specified | Uncertain significance (Jul 10, 2024) | ||
16-68370902-C-T | not specified | Uncertain significance (May 22, 2023) | ||
16-68370934-C-T | not specified | Uncertain significance (Aug 09, 2021) | ||
16-68370995-C-T | not specified | Uncertain significance (Jan 17, 2024) | ||
16-68371005-C-T | not specified | Uncertain significance (Sep 04, 2024) | ||
16-68371155-C-T | not specified | Uncertain significance (Jan 02, 2024) | ||
16-68371166-C-T | not specified | Uncertain significance (Jan 02, 2024) | ||
16-68371179-C-T | not specified | Uncertain significance (Jul 20, 2021) | ||
16-68371190-T-C | not specified | Uncertain significance (Feb 16, 2023) | ||
16-68371194-C-A | not specified | Uncertain significance (Aug 05, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SMPD3 | protein_coding | protein_coding | ENST00000219334 | 7 | 90361 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.594 | 0.406 | 125723 | 0 | 12 | 125735 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.11 | 356 | 420 | 0.848 | 0.0000282 | 4181 |
Missense in Polyphen | 96 | 156.71 | 0.61261 | 1588 | ||
Synonymous | -1.34 | 228 | 204 | 1.12 | 0.0000156 | 1368 |
Loss of Function | 3.66 | 5 | 24.6 | 0.203 | 0.00000140 | 254 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000166 | 0.0000905 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.0000445 | 0.0000440 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the hydrolysis of sphingomyelin to form ceramide and phosphocholine. Ceramide mediates numerous cellular functions, such as apoptosis and growth arrest, and is capable of regulating these 2 cellular events independently. Also hydrolyzes sphingosylphosphocholine. Regulates the cell cycle by acting as a growth suppressor in confluent cells. Probably acts as a regulator of postnatal development and participates in bone and dentin mineralization. {ECO:0000269|PubMed:10823942, ECO:0000269|PubMed:14741383, ECO:0000269|PubMed:15051724}.;
- Pathway
- Sphingolipid metabolism - Homo sapiens (human);Signal Transduction;Metabolism of lipids;sphingomyelin metabolism/ceramide salvage;Metabolism;Glycosphingolipid metabolism;TNFR1-mediated ceramide production;TNF signaling;Death Receptor Signalling;Glycosphingolipid metabolism;Sphingolipid metabolism;TNFalpha;Ceramide signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.183
Intolerance Scores
- loftool
- 0.152
- rvis_EVS
- -0.91
- rvis_percentile_EVS
- 10.12
Haploinsufficiency Scores
- pHI
- 0.351
- hipred
- Y
- hipred_score
- 0.687
- ghis
- 0.555
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.984
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Smpd3
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; skeleton phenotype;
Gene ontology
- Biological process
- hematopoietic progenitor cell differentiation;sphingomyelin metabolic process;sphingomyelin catabolic process;cell cycle;peptide hormone secretion;positive regulation of exosomal secretion;positive regulation of ceramide biosynthetic process
- Cellular component
- Golgi cis cisterna;Golgi membrane;cytoplasm;plasma membrane
- Molecular function
- sphingomyelin phosphodiesterase activity;protein binding;metal ion binding